I Pledge Allegiance
February 24, 2006
Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.
DONATEThis website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.
We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.
This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by clicking on the “I agree” button or by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy Policy and Terms of Use.
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.
This symposium presents a remarkable opportunity to convene with other researchers, clinicians, and industry leaders to discuss the extraordinary progress and immense potential of new drug therapies and technologies in paving the way for a brighter future in cancer treatment.
Scientists working in basic, translational, and clinical cancer metabolism research are invited to join the Academy in New York on April 17th to discuss the intersection between cell signaling and metabolism.
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.
The Leon Levy Scholarships in Neuroscience (LLSN) aim to promote groundbreaking neuroscience research in the five boroughs of New York City. The scholarships support the most innovative young researchers at a critical stage of their careers—their postdoctoral research—as they develop the new ideas and directions that will help establish them as independent neuroscientists.
As the New York Academy of Sciences continues into its third century, Nicholas Dirks is at the helm of an extraordinary organization with a talented staff, a global community of more than 20,000 Members, and a network of top-echelon leaders in science, industry, academia, government and public policy. Bringing all these people together, the Academy is taking on COVID-19 and other world-wide challenges with the best solutions that science, technology, and bright minds can offer.
February 24, 2006